| Similar Articles |
|---|
 |
The Motley Fool
May 6, 2008
Steven Renaldi |
McKesson Garners Generic Growth New products offer the generic-drug distributor profit potential in a competitive industry.   |
The Motley Fool
October 12, 2004
W.D. Crotty |
A Bargain in Drug Distribution? D&K Healthcare Resources' stock surprises investors, but the drop brings a favorable valuation. |
The Motley Fool
May 6, 2005
W.D. Crotty |
McKesson's New Pep Pill The drug wholesaler reports strong fourth-quarter results as it moves to a fee-for-service model. |
The Motley Fool
October 8, 2007
Billy Fisher |
McKesson Expands Its Empire A new acquisition strengthens the company's presence in the cancer drug market. Investors, take note. |
The Motley Fool
January 2, 2004
Alyce Lomax |
A Bitter Pill for Amerisource Veterans ditch Amerisource for rival; investors punish the entire pharmaceutical distribution industry. |
The Motley Fool
June 13, 2006
Ryan Fuhrmann |
Cardinal Looks to Deliver Cardinal Health has been through a tumultuous couple of years but appears to have weathered company-specific and industry storms. If the drug distributor can meet its long-term goals, then its stock should represent a long-term solid investment. |
The Motley Fool
January 26, 2004
Alyce Lomax |
Amerisource's Fightin' Words Wholesale drug distributor AmerisourceBergen's first-quarter profits rise, but will a fight with veterans end peacefully? |
The Motley Fool
October 26, 2005
Stephen D. Simpson |
Cardinal's Tweet More Sweet Changes at the giant manufacturer, distributor, and service provider in the health-care industry are working out well, but the stock price already reflects it. |
The Motley Fool
July 1, 2004
W.D. Crotty |
Drug Wholesalers Taking a Beating A sharp drop at drug wholesaler Cardinal Health provides a unique buying opportunity. |
The Motley Fool
October 25, 2004
Tom Taulli |
McKesson Gets Pain Relief Drug distributors would like to forget 2004. But this may mean bargains for investors. |
BusinessWeek
August 7, 2006
Arlene Weintraub |
McKesson's Booster Shot McKesson Corp. holds the unenviable distinction of being one of the world's biggest yet least profitable companies. The problem: huge sales, tiny profits. High-margin tech products could help. |
BusinessWeek
August 30, 2004
Gene G. Marcial |
PSS Is Really Delivering The Goods When David Smith took the CEO job at PSS World Medical in 2000, sales stood at $160 million. They've since rocketed to $1.35 billion. No wonder industry giants are eyeballing the company: They hope Smith will sell. |
The Motley Fool
March 9, 2005
W.D. Crotty |
WebMD's Misleading Results WebMD reports good numbers, but the stock looks pricey. |
The Motley Fool
March 31, 2006
Nathan Parmelee |
The Business of Buybacks What do stock repurchases mean for your portfolio? |
The Motley Fool
February 1, 2006
Rich Duprey |
Candela Is Finally White Hot The aesthetic laser maker finally produces the white-hot sales growth it promised -- two years ago. In midday trading, the stock soared 30%. |
The Motley Fool
August 3, 2006
Ryan Fuhrmann |
Cardinal Distributes the Goods The drug wholesaler and distributor has to regain investor confidence and rebuild a track record in a changed industry. So far, so good for 2006. Let's see if any further information can be found once Cardinal submits its 10-K filing to the SEC. |
The Motley Fool
June 1, 2010
Rick Aristotle Munarriz |
4 Dividend Stocks Showing You the Money These companies have recently raised their dividends: UnitedHealth Group... H.J. Heinz... Williams-Sonoma... Lowe's... |
The Motley Fool
December 22, 2010
Seth Jayson |
Here's How McKesson Is Making So Much for You With TTM margins all at a five-year high, McKesson looks like it's doing great. |
The Motley Fool
September 12, 2006
Rich Duprey |
A Fuzzy Forecast for Candela Based on company-specific trends, the balance of 2006 will be a bust for the aesthetic laser maker. Investors, take note. |
The Motley Fool
April 26, 2004
Alyce Lomax |
Amerisource Hangs On While pharmaceutical distribution is an industry with obvious opportunities for financial reward, the potential for a price war remains a risk. |
The Motley Fool
August 24, 2010
David Meier |
Can McKesson Produce Big Returns? McKesson uses its production advantage -- high asset turnover and reasonable leverage -- to generate very attractive returns on equity for shareholders. |
The Motley Fool
May 21, 2007
Anders Bylund |
Foolish Forecast: Svelte Tech Data The tech equipment distributor is set to reports its quarterly earnings. Investors, here is what you can expect to find. |
The Motley Fool
May 28, 2004
Richard Gibbons |
Quality Systems a Picture of Health Earnings are great, but can the medical systems developer maintain its torrid growth rate? |
The Motley Fool
May 7, 2004
Mark Mahorney |
WebMD Not a Sure Winner WebMD, providers of online health information, electronic data interchange services and practice management software and services to the healthcare industry, improved slightly during the first quarter, and it looks to be more of the same ahead. |
The Motley Fool
July 25, 2011
Morgan Housel |
4 Companies You Can Buy Today These are cheap by the numbers. |
